PubMed

Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular disease.

Zandbergen AA, Sijbrands EJ, Lamberts SW, Bootsma AH.

Diabetes Care. 2006 Aug;29(8):1851-5.PMID: 16873791 [PubMed - indexed for MEDLINE]Related articlesFree article

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R.

Arch Intern Med. 1998 May 11;158(9):998-1004.PMID: 9588433 [PubMed - indexed for MEDLINE]Related articlesFree article

A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up.

Rius Riu F, Salinas Vert I, Lucas Martín A, Romero González R, Sanmartí Sala A.

J Diabetes Complications. 2003 Sep-Oct;17(5):235-42.PMID: 12954150 [PubMed - indexed for MEDLINE]Related articles

The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus.

Valmadrid CT, Klein R, Moss SE, Klein BE.

Arch Intern Med. 2000 Apr 24;160(8):1093-100.PMID: 10789601 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association.

De Cosmo S, Minenna A, Ludovico O, Mastroianno S, Di Giorgio A, Pirro L, Trischitta V.

Diabetes Care. 2005 Apr;28(4):910-5.PMID: 15793194 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.

Romero P, Salvat M, Fernández J, Baget M, Martinez I.

J Diabetes Complications. 2007 Mar-Apr;21(2):93-100.PMID: 17331857 [PubMed - indexed for MEDLINE]Related articles

Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.

Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo Perin P; Casale Monferrato Study.

Diabetes Care. 2003 Jul;26(7):2150-5.PMID: 12832328 [PubMed - indexed for MEDLINE]Related articlesFree article

Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria.

Spoelstra-de Man AM, Brouwer CB, Stehouwer CD, Smulders YM.

Diabetes Care. 2001 Dec;24(12):2097-101.PMID: 11723090 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated levels of plasma von Willebrand factor and the risk of macro- and microvascular disease in type 2 diabetic patients with microalbuminuria.

Gaede P, Vedel P, Parving HH, Pedersen O.

Nephrol Dial Transplant. 2001 Oct;16(10):2028-33.PMID: 11572892 [PubMed - indexed for MEDLINE]Related articlesFree article

Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus.

Tong PC, Kong AP, So WY, Yang X, Ng MC, Ho CS, Ma RC, Ozaki R, Ng V, Chow CC, Lam CW, Chan JC, Cockram CS.

Diabet Med. 2007 Jul;24(7):741-6. Epub 2007 Apr 2.PMID: 17403120 [PubMed - indexed for MEDLINE]Related articles

Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria.

Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.

Nephrol Dial Transplant. 2001 Mar;16(3):529-36.PMID: 11239027 [PubMed - indexed for MEDLINE]Related articlesFree article

The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.

Soedamah-Muthu SS, Visseren FL, Algra A, van der Graaf Y; SMART Study Group.

Diabet Med. 2008 Jan;25(1):51-7.PMID: 18199132 [PubMed - indexed for MEDLINE]Related articles

Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?

Herrera-Pombo JL, Aguilar-Diosdado M, Hawkins F, Campos MM, Moreno A, Garcia-Hernandez A, Castro E, García-Doncel LG, Serraclara A, Sánchez-Malo C, Escobar-Jiménez F.

Nephron Clin Pract. 2005;101(3):c116-21. Epub 2005 Jul 5.PMID: 16015000 [PubMed - indexed for MEDLINE]Related articles

Gender difference in the impact of type 2 diabetes on coronary heart disease risk.

Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

Diabetes Care. 2004 Dec;27(12):2898-904.PMID: 15562204 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR; UKPDS Study Group.

Diabetes. 2006 Jun;55(6):1832-9.PMID: 16731850 [PubMed - indexed for MEDLINE]Related articlesFree article

A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM.

Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J.

Diabetes Care. 1993 Jul;16(7):996-1003.PMID: 8359108 [PubMed - indexed for MEDLINE]Related articles

Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality.

Beilin J, Stanton KG, McCann VJ, Knuiman MW, Divitini ML.

Aust N Z J Med. 1996 Aug;26(4):519-25.PMID: 8873935 [PubMed - indexed for MEDLINE]Related articles

Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04).

Wilcox R, Bousser MG, Betteridge DJ, Schernthaner G, Pirags V, Kupfer S, Dormandy J; PROactive Investigators.

Stroke. 2007 Mar;38(3):865-73. Epub 2007 Feb 8.PMID: 17290029 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes.

Araki S, Haneda M, Koya D, Hidaka H, Sugimoto T, Isono M, Isshiki K, Chin-Kanasaki M, Uzu T, Kashiwagi A.

Diabetes. 2007 Jun;56(6):1727-30. Epub 2007 Mar 14.PMID: 17360976 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4.

Forsblom CM, Sane T, Groop PH, Tötterman KJ, Kallio M, Saloranta C, Laasonen L, Summanen P, Lepäntalo M, Laatikainen L, Matikainen E, Teppo AM, Koskimies S, Groop L.

Diabetologia. 1998 Nov;41(11):1253-62.PMID: 9833930 [PubMed - indexed for MEDLINE]Related articles